ProShare Advisors’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

ProShare Advisors’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-3,471	Closed	-$369K	–	2452
2014 Q2	$369K	Sell	3,471 -3,246	-48%	-$318K	﹤0.01%	1774
2014 Q1	$584K	Buy	+6,717	New	+$519K	0.01%	1746
2013 Q4	–	Sell	-7,815	Closed	-$344K	–	2408
2013 Q3	$344K	Buy	7,815 +1,095	+16%	+$45.3K	0.01%	1786
2013 Q2	$229K	Buy	+6,720	New	+$236K	﹤0.01%	1927

ProShare Advisors's FURX Position: Q3 2014 in Review

ProShare Advisors sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 3,471 shares — an estimated $369K sold.

ProShare Advisors first reported a position in FURX in Q2 2013 and held it in 4 quarters. The position peaked at $584K in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

ProShare Advisors reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
ProShare Advisors sold 3,471 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $369K.
ProShare Advisors first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
ProShare Advisors's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $584K in Q1 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on ProShare Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.